318 related articles for article (PubMed ID: 8826565)
1. Dual calcium-channel blocker therapy in the treatment of hypertension.
Saseen JJ; Carter BL
Ann Pharmacother; 1996; 30(7-8):802-10. PubMed ID: 8826565
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of dual calcium channel blockade for the treatment of hypertension: a meta-analysis.
Alviar CL; Devarapally S; Nadkarni GN; Romero J; Benjo AM; Javed F; Doherty B; Kang H; Bangalore S; Messerli FH
Am J Hypertens; 2013 Feb; 26(2):287-97. PubMed ID: 23382415
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension.
Flynn JT; Pasko DA
Pediatr Nephrol; 2000 Dec; 15(3-4):302-16. PubMed ID: 11149130
[TBL] [Abstract][Full Text] [Related]
4. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
Opie LH; Yusuf S; Kübler W
Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
Opie LH
Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Ledingham JG; Petrie JC; Webster J
J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
[TBL] [Abstract][Full Text] [Related]
7. High-dose calcium channel blocker (CCB) monotherapy vs combination therapy of standard-dose CCBs and angiotensin receptor blockers for hypertension: a meta-analysis.
He T; Liu X; Li Y; Liu XY; Wu QY; Liu ML; Yuan H
J Hum Hypertens; 2017 Feb; 31(2):79-88. PubMed ID: 27511478
[TBL] [Abstract][Full Text] [Related]
8. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
Makarounas-Kirchmann K; Glover-Koudounas S; Ferrari P
Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
[TBL] [Abstract][Full Text] [Related]
9. Nondihydropyridine Calcium Channel Blockers for the Treatment of Proteinuria: A Review of the Literature.
Steuber TD; Lee J; Holloway A; Andrus MR
Ann Pharmacother; 2019 Oct; 53(10):1050-1059. PubMed ID: 30966785
[No Abstract] [Full Text] [Related]
10. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
11. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
Onoda JM; Nelson KK; Taylor JD; Honn KV
Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
[TBL] [Abstract][Full Text] [Related]
12. Update on calcium-channel blocking agents.
Talbert RL; Bussey HI
Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
[TBL] [Abstract][Full Text] [Related]
13. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel blockers: monotherapy and dual therapy considerations in the treatment of hypertension.
Sica DA
Am J Cardiovasc Drugs; 2007; 7 Suppl 1():1-3. PubMed ID: 19847946
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
Oparil S; Weber M
Postgrad Med; 2009 Mar; 121(2):25-39. PubMed ID: 19332960
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blockers in cardiovascular pharmacotherapy.
Godfraind T
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
[TBL] [Abstract][Full Text] [Related]
18. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup.
Wong A; Hoffman RS; Walsh SJ; Roberts DM; Gosselin S; Bunchman TE; Kebede S; Lavergne V; Ghannoum M;
Clin Toxicol (Phila); 2021 May; 59(5):361-375. PubMed ID: 33555964
[TBL] [Abstract][Full Text] [Related]
20. High blood pressure and calcium antagonism.
Palma-Gámiz JL
Cardiology; 1997; 88 Suppl 1():39-46. PubMed ID: 9118167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
